Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/01/2012WO2012106522A3 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
11/01/2012WO2012106404A3 Diagnosis and treatment of neurological disorders through vipr2 and vpac2r
11/01/2012WO2012104874A3 Aqueous concentrated formulation of linezolid
11/01/2012WO2012103456A3 Polycyclic beta lactam derivatives for the treatment of cancer
11/01/2012WO2012100045A9 Methods of predicting response to jnk inhibitor therapy
11/01/2012WO2012097330A3 Compositions and methods for treating degenerative muscle conditions
11/01/2012WO2012097133A3 Compounds and methods for inducing apoptosis in cancer cells using a bh3 alpha-helical mimetic
11/01/2012WO2012094437A3 Nicotinic receptor non-competitive antagonists
11/01/2012WO2012092486A3 Modified release benzimidazole formulations
11/01/2012WO2012088100A3 Triclabendazole and fenbendazole for cell protection
11/01/2012WO2012088044A3 Compositions and methods for improving ocular surface health, corneal clarity, optical function and maintaining visual acuity
11/01/2012WO2012088001A3 Antiviral activity of bovine type iii interferon against foot-and-mouth disease virus
11/01/2012WO2012083138A3 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
11/01/2012WO2012076961A3 Carnosine - hyaluronic acid mixtures and their use
11/01/2012WO2012068406A3 Use of hematopoietic growth factor mimetics
11/01/2012WO2012066234A9 Novel indolizine derivatives, and preparation and therapeutic use thereof
11/01/2012WO2012038850A8 Pyrimidones for treatment of potassium channel related diseases
11/01/2012WO2012007539A9 Ip receptor agonist heterocyclic compounds
11/01/2012WO2011140202A3 Mif modulators
11/01/2012WO2011086134A9 Treatment of chlamydiaceae infections by means of beta-lactams
11/01/2012WO2007049041A8 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
11/01/2012US20120278912 Genetic suppression and replacement
11/01/2012US20120277772 Hppe yarns
11/01/2012US20120277694 Punctal plug with active agent
11/01/2012US20120277434 Methods for synthesizing quinolinone compounds
11/01/2012US20120277320 Inhibition of the survival of skin cancer by cyclohexenone compounds from antrodia camphorata
11/01/2012US20120277319 Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety
11/01/2012US20120277318 Non-steroidal anti-inflammatory drugs for cough
11/01/2012US20120277317 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-related diseases
11/01/2012US20120277316 Methods and compositions for treating and preventing parenteral nutrition associated liver disease
11/01/2012US20120277315 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
11/01/2012US20120277314 catheter lock solution comprising citrate and a paraben
11/01/2012US20120277312 Ethylgallate and Related Compounds as a Treatment for Sepsis and Septic Shock
11/01/2012US20120277311 Lipoxin compounds and their use in treating cell proliferative disorders
11/01/2012US20120277310 Novel conjugates for treating neurodegenerative diseases and disorders
11/01/2012US20120277309 Methods of controlling venous irritation associated with the treatment of a cardiac disorder
11/01/2012US20120277308 compounds for treating cancer and other diseases
11/01/2012US20120277307 Method for Treating Osteoarthritis
11/01/2012US20120277306 Composition containing metal-acidic amino acid chelate accelerating absorption of metal
11/01/2012US20120277305 Fatty acid guanidine and salicylate guanidine derivatives and their uses
11/01/2012US20120277304 Sodium transhinone iia sulfonate hydrate and preparation method and use thereof
11/01/2012US20120277303 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
11/01/2012US20120277302 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
11/01/2012US20120277301 Chroman-derived anti-androgens for treatment of androgen mediated disorders
11/01/2012US20120277300 Compositions and methods for inducing bone growth and inhibiting bone loss
11/01/2012US20120277299 Method for modulating ion transporter
11/01/2012US20120277298 Flavanones-containing food compositions
11/01/2012US20120277297 Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors
11/01/2012US20120277296 Selective CB2 Receptor Agonists for Use in the Prevention or Treatment of Alcoholic Liver Disease
11/01/2012US20120277295 Kit for cancer treatment and pharmaceutical composition for cancer treatment
11/01/2012US20120277294 Functional food additives
11/01/2012US20120277293 Immunostimulatory Method
11/01/2012US20120277292 ANTISENSE OLIGONUCLEOTIDES AGAINST cPLA2, COMPOSITIONS AND USES THEREOF
11/01/2012US20120277291 Preventive for adhesion following abdominal surgery
11/01/2012US20120277290 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277288 Means and Methods for the Specific Modulation of Target Genes in the CNS and the Eye and Methods for Their Identification
11/01/2012US20120277287 Modulating the CDC14B-CDH1-PLK1 Axis and Methods for Sensitizing Target Cells to Apoptosis
11/01/2012US20120277286 Compositions and methods for the treatment or prevention of mitochondrial diseases
11/01/2012US20120277285 Control of gene expression
11/01/2012US20120277284 Modulation of signal transducer and activator of transcription 3 (stat3)expression
11/01/2012US20120277283 Localized Delivery of Gold Nanoparticles for Therapeutic and Diagnostic Applications
11/01/2012US20120277282 Polynucleotides for use in medicine
11/01/2012US20120277281 Polynucleotides for medical use
11/01/2012US20120277280 Phenoxy-pyrrolidine derivative and its use and compositions
11/01/2012US20120277279 Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions
11/01/2012US20120277278 Phenylbutazone carrier formulation showing increased bioactivity in animals
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277275 Azole and thiazole derivatives and their use
11/01/2012US20120277274 Epothilone compound formulations
11/01/2012US20120277273 Small molecule inhibitors of rgs proteins
11/01/2012US20120277272 Ethanamine Compounds and Methods of Using the Same
11/01/2012US20120277271 Methods and compositions
11/01/2012US20120277270 Method for Decreasing Symptoms of Alcohol Consumption
11/01/2012US20120277269 Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy
11/01/2012US20120277268 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
11/01/2012US20120277267 Method of managing or treating pain
11/01/2012US20120277266 Hepatitis C Virus Inhibitors
11/01/2012US20120277265 Novel polyquinoline derivatives and the therapeutic use thereof
11/01/2012US20120277264 Antithrombotic agent
11/01/2012US20120277263 Polymorphs of 1-cyclopropyl-7-([s,s])-2,8-diazadicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro -8-methoxy-4-oxo-3-quinoline carboxylic acid hydrochloride and methods for the preparation thereof
11/01/2012US20120277262 New aminotetraline derivatives
11/01/2012US20120277261 Pharmaceutical formulations useful in the treatment of insomnia
11/01/2012US20120277260 Use of methylnaltrexone and related compounds to treat constipation in chronic opioid users
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277258 Chemical Compounds
11/01/2012US20120277257 Methods of Treating Diseases, Pharmaceutical Compositions, and Pharmaceutical Dosage Forms
11/01/2012US20120277256 Frequency modulated drug delivery (fmdd)
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277254 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277253 Subcutaneous paliperidone composition
11/01/2012US20120277252 Antibacterial Agents and Methods of Use Thereof
11/01/2012US20120277251 Analogs of dehydrophenylahistins and their therapeutic use
11/01/2012US20120277250 Amidine-containing compounds useful as muscarinic receptor antagonists
11/01/2012US20120277249 Parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
11/01/2012US20120277248 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/01/2012US20120277247 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012US20120277246 Use of N-Phenyl-2-pyrimidineamine Derivatives Against Mast Cell-based Diseases Like Allergic Disorders
11/01/2012US20120277245 Method of Increasing Intratumoral pHe and Reducing Acid-Mediated Invasion
11/01/2012US20120277244 Pyrazine derivatives and their use in the treatment of neurological disorders
1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 7860